3Matsumotok, Fujiih, Michalopoulos G, et al. Human biliary epithelial cells secrete and respond to cytokines and hepocyte growth factors in vitro interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro[ J]. Hepatology, 1994,20(2) : 376-382.
4Shimizu Y, Demetris AJ, Gonin SM, et al. Two new humancholangiocarcinoma cell lines and their cytogenetics and responses to growthfactors,hormones, cytokinesOrimmunologiceffectorcells [J].Int J Cance, 1992,52(2) :252-260.
5Su MC, Hsu C, Kao HL, et al. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma[ J ]. Cancer Lett, 2006,235 ( 1 ) : 34-39.
6Becker JC, Termeer C, Schmidt RE, et al. Soluble intercellular adhesion molecul-1 inhibits MHC-restricted specific T cell/tumor interaction[J]. J Immunnl, 1993,151 (12) :7224-7232.
7Neng F,Yamagwa Y, Ueno Y, et al. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes[ J] .J Hepateol,2006,44(6) : 1055-1065.
8Yamagiwa Y, Meng F,Patel T.Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangicoytes[ J]. Life Sci,2006,78(21) :2494-2502.
9Isomoto H, Kobayashi S, Wemeburg NW, et al.Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells[J]. Hepatology,2005,42(6) : 1329-1338.
10Tangkijvanich P,Thong-ngam D, Theamboonlers A, et al. Diagnostic role of serum interleukin 6 and CA19-9 in patients with cholangiocarcinoma[ J].Hepatogastroenterology, 2004,51 (55) :15-19.
